Showing 1 - 5 results of 5 for search 'Marinier, K', query time: 0.02s
Refine Results
-
1
-
2
Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment by Prats-Uribe, A, Illingens, B, Vizcaya, D, Weaver, J, Burn, E, Sawant, R, Marinier, K, Ryan, P, Prieto-Alhambra, D, European Hlth Data Evidence
Published 2020Conference item -
3
Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU‐ADR Alliance by Berencsi, K, Ali, M, Marinier, K, Deltour, N, Hawley, S, Pedersen, L, Rijnbeek, P, Van Der Lei, J, Lapi, F, Simonetti, M, Reyes, C, Sturkenboom, M, Prieto-Alhambra, D
Published 2018Conference item -
4
Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: a multi-database study in our European countries by the EU-A... by Ali, M, Berencsi, K, Marinier, K, Deltour, N, Hawley, S, Pedersen, L, Rijnbeek, P, Duijnhoven, R, Van Der Lei, J, Lappi, F, Simonetti, M, Reyes-Reyes, C, Sturkenboom, M, Prieto-Alhambra, D
Published 2017Conference item -
5
Impact of risk minimisation measures on the use of strontium ranelate: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance by Berencsi, K, Ali, M, Marinier, K, Deltour, N, Hawley, S, Pedersen, L, Rijnbeek, P, Duijnhoven, R, Van Der Lei, J, Lapi, F, Simonetti, M, Reyes-Reyes, C, Sturkenboom, M, Prieto-Alhambra, D
Published 2017Conference item